Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Teachers ‘don’t know enough grammar to teach curriculum’

10 October 2013

Many teachers do not have adequate knowledge of English grammar to teach the new curriculum, according to the architect of a government-funded teaching programme. 

Bas Aarts, a professor of English linguistics at UCL, is designing Englicious, an online tool that will give schools access to one of Britain’s biggest databases of the English language. 

Read the full story at thetimes.co.uk (please note this is behind a paywall).

Related success story

iGE: Grammar on the Go